OstroVit MCT Oil Powder 200 g

The OstroVit MCT Oil dietary supplement is a high-quality product that provides a source of valuable MCT oil. This oil contains many active ingredients, including caproic acid, caprylic acid, capric acid, lauronic acid, myristic acid, and palmitic acid. OstroVit's product has a simple composition and is free of unnecessary additives, preservatives, enhancers, and colorings. It comes in powder form.

MCT oil is a blend of the highest quality medium-chain fatty acids. It differs from saturated fats in that it is digested much faster. It is absorbed in the liver, not in the intestines like other fats. MCTs consist of 6-10 carbon atoms. They are found primarily in the coconut palm.

Caprylic acid is a substance with the ability to acylate ghrelin, the hunger hormone. Acylating ghrelin inhibits its orexogenic effect and thus reduces hunger. [1]

MCTs also contribute to lowering LDL cholesterol ("bad" cholesterol) and increasing HDL cholesterol ("good" cholesterol). They have similar properties to olive oil. [2]

Caprylic acid contributes to the restoration of cognitive function in people who have experienced cognitive decline. It follows that MCT supplementation may promote cognitive processes. [3]

In summary, the OstroVit MCT Oil dietary supplement is a high-quality product that provides valuable MCT oil. This substance is a blend of medium-chain fatty acids with numerous health-promoting properties. The formula has a simple, pure composition and a convenient liquid form.

1 Lemarié F, Beauchamp E, Legrand P, Rioux V. Review of the metabolism and physiological functions of caprylic acid (C8:0) with particular attention to ghrelin acetylation. Biochimie. 2016 Jan;120:40-8. doi: 10.1016/j.biochi.2015.08.002. Epub 2015 Aug 4. PMID: 26253695.

2 St-Onge MP, Bosarge A, Goree LL, Darnell B. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J Am Coll Nutr. 2008 Oct;27(5):547-52. doi: 10.1080/07315724.2008.10719737. PMID: 18845704; PMCID: PMC2874191.

3 Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Study of the ketogenic drug AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (London). 2009 Aug 10;6:31. doi: 10.1186/1743-7075-6-31. PMID: 19664276; PMCID: PMC2731764.